Rekovelle

Rekovelle Use In Pregnancy & Lactation

follitropin delta

Manufacturer:

Ferring

Distributor:

Zuellig Pharma
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: REKOVELLE is not indicated during pregnancy. No teratogenic risk has been reported, following controlled ovarian stimulation, in clinical use with gonadotropins. There are no data from the inadvertent exposure to REKOVELLE in pregnant women. Studies in animals have shown reproductive toxicity with REKOVELLE doses above the recommended maximal dose in humans (see Pharmacology: Toxicology: Preclinical Safety Data under Actions).
Breastfeeding: REKOVELLE is not indicated during breastfeeding.
Fertility: REKOVELLE is indicated for use in infertility (see Indications).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in